Company / Working Capital per Share
Cogent Biosciences, Inc. Working Capital per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$6.57
FY2025
5-year range
$2.32 / $6.57
FY2021-FY2025
Trend
+183.3%
vs FY2024
Sector context
#80 of 210
Health Care
What the data says
At $6.57, Cogent Biosciences, Inc.'s working capital per share ranks #80 of 210 in the Health Care sector. Working Capital per Share returned to growth in FY2025 after 4 years of decline, reaching $6.57.
Based on SEC 10-K filings.
6.57 in FY2025 with a 5-year CAGR of -20.7%.
Improved from $2.92 to $6.57 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +17.4%
- 5-Year CAGR
- -20.7%
- 10-Year CAGR
- -
Sector benchmark
#80 of 210 in Health CareTop 38% of 210This company $6.57 Sector average $146.71
▼
-95.5% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 183.3% year-over-year.
- Ranks #80 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.57 | +183.3% |
| FY2024 | $2.32 | -20.6% |
| FY2023 | $2.92 | -28.0% |
| FY2022 | $4.05 | -23.6% |
| FY2021 | $5.31 | -74.6% |
| FY2020 | $20.92 | +483.0% |
| FY2019 | $3.59 | +59.4% |
| FY2018 | $2.25 | -26.4% |
| FY2017 | $3.06 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026